"A Pilot Study of OncozeneTM Microspheres for Intra-arterial Delivery of Doxorubicin"

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 21, 2015

Primary Completion Date

June 22, 2018

Study Completion Date

May 16, 2022

Conditions
Hepatocellular Cancer
Interventions
OTHER

Oncozene-DEB-TACE

ONCOZENE microspheres are the newly available microspheres for DEB-TACE. It appears (based on the preliminary bench tests) that these microspheres may allow more efficient drug loading, and slow elution and equivalent vascular occlusion(12). In this pilot study, we aim to assess the safety of these microspheres when used for chemoembolization of unresectable hepatocellular carcinoma.

Trial Locations (1)

75390

UT Southwestern Medical Center, Dallas

All Listed Sponsors
lead

University of Texas Southwestern Medical Center

OTHER

NCT02141906 - "A Pilot Study of OncozeneTM Microspheres for Intra-arterial Delivery of Doxorubicin" | Biotech Hunter | Biotech Hunter